April 18, 2014 9:35 PM ET

Pharmaceuticals

Company Overview of Presidio Pharmaceuticals, Inc.

Executive Profile

Edward Arnold Ph.d.

Member of Clinical & Science Advisory Board, Presidio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Edward Arnold, Ph.d. is a Professor II of Chemistry and Chemical Biology, Rutgers University. Dr. Arnold serves as Member of the Clinical & Science Advisory Board of Presidio Pharmaceuticals, Inc. His team solved the three-dimensional structures of HIV-1 RT in complex with antiviral drugs and pieces of the HIV genome, including new NNRTI candidates from Tibotec.

Corporate Headquarters

1700 Owens Street
San Francisco, California 94158

United States

Phone: 415-655-7560
Fax: 415-986-2864

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Presidio Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.